Skip to content

IAS: Roche admits long-standing low-level contamination of nelfinavir

IAS: Regular viral load testing essential for patients in resource limited settings on NNRTIs, says US resistance expert

Maraviroc gets scientific thumbs up from European drugs body

Sustainability of antiretroviral therapy in HIV-infected adult urban Kenyans: lessons for other resource-poor countries

Frequent switchers have lower quality of life, higher suicidality

Treatment failure and drug resistance not associated with rapid death or illness in Côte d’Ivoire study

Darunavir superior to lopinavir in 48-week study in treatment-experienced patients

Risk of viral rebound decreases with longer treatment, even with previous failures

Four-year analysis of tenofovir finds “favourable safety profile”